
product.sku
CZpi-Defumoxan
product.category
Nicotine Replacement Therapies
product.brand
Aflofarm Farmacja Polska Sp. z o.o.
product.supplier
Beyston
product.weight
0.1kg
product.description
Defumoxan 1.5 mg tablets are used to support smoking cessation by helping to reduce nicotine cravings and withdrawal symptoms. The active ingredient, cytisine, partially stimulates nicotine receptors in the brain, reducing the urge to smoke and making it easier to quit.
Use according to the Defumoxan treatment schedule or as directed by a healthcare professional. The typical treatment lasts 25 days, with a gradual reduction in the number of tablets per day while quitting cigarettes. Do not exceed the recommended dosage.
Defumoxan, cytisine, smoking cessation, quit smoking aid, nicotine withdrawal support, nicotine receptor therapy, anti-smoking tablets.